title: [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
abstract: We present the case of a young man who developed severe cardiomyopathy eight years after receiving high-dose doxorubicin therapy as treatment for diffuse lymphoblastic lymphoma. He underwent cardiac transplantation and eighteen months later the tumor has not recurred and the patient has no cardiac symptoms.
authors: Servicio de Cardiología, Clínica Puerta de Hierro, Madrid.
authors: J A
authors: JA
authors: Rubio
authors: L A
authors: LA
authors: Pulpón
authors: M A
authors: MA
authors: Cavero
authors: J F
authors: JF
authors: Oteo
authors: C
authors: C
authors: Maicas
authors: L
authors: L
authors: Silva
authors: S
authors: S
authors: Serrano-Fiz
authors: R
authors: R
authors: Burgos
authors: M
authors: M
authors: Artaza
authors: G
authors: G
authors: Téllez
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009206:Myocardium / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin
vernacular_title: Trasplante cardíaco en un paciente con miocardiopatía por doxorrubicina como complicación del tratamiento de un linfoma.